AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34032739 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand treatment with nonacog alfa
Number of subjects: 70
Study 34032739 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with nonacog alfa
Number of subjects: 70
Study 34032739 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall safety of nonacog alfa
Number of subjects: 70
Study 32583300 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant and transdermal scopolamine preoperatively followed by ondansetron and dexamethasone intraoperatively, with total intravenous anesthesia.
Number of subjects: 83
Study 32583300 — intervention group
Group type: COMPARATOR
Intervention: Inhalational anesthetic and two intraoperative antiemetics without preoperative prophylaxis.
Number of subjects: 83
Study 32583300 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (aprepitant and transdermal scopolamine)
Number of subjects: 83
Study 35202361 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded amalgam sealants (BAS)
Number of subjects: 38
Study 35202361 — intervention group
Group type: COMPARATOR
Intervention: Conventional resin‐based sealant (RBS)
Number of subjects: 38
Study 33216048 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape vinegar and rose water solution
Number of subjects: 60
Study 33216048 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash
Number of subjects: 60
Study 34599744 — intervention group
Group type: EXPERIMENTAL
Intervention: ART + Brix3000™
Number of subjects: 20
Study 34599744 — intervention group
Group type: COMPARATOR
Intervention: ART (control)
Number of subjects: 20
Study 34599744 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ART + Brix3000™ and ART)
Number of subjects: 20
Study 32023809 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU vitamin D3 supplementation
Number of subjects: 20
Study 32023809 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 IU vitamin D3 supplementation
Number of subjects: 20
Study 32023809 — intervention group
Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 20
Study 35120505 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based education (3 training sessions of 60 to 90 minutes)
Number of subjects: 71
Study 33754809 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 or 25 mg
Number of subjects: 7020
Study 33754809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study 33050893 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory of planned behavior (TPB) based oral health education consisting of four one-hour training sessions over 1 week.
Number of subjects: 356
Study 33050893 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 356
Study 36078441 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention designed with Behavior Change Wheel (BCW)
Number of subjects: 60
Study 36078441 — intervention group
Group type: COMPARATOR
Intervention: General dietary management (control group)
Number of subjects: 60
Study 34801714 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine 200 mg weekly
Number of subjects: 600
Study 34801714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study 34097713 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg ml‐1 S‐ketamine in oxycodone PCA
Number of subjects: 100
Study 34097713 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg ml‐1 S‐ketamine in oxycodone PCA
Number of subjects: 100
Study 34097713 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg ml‐1 S‐ketamine in oxycodone PCA
Number of subjects: 100
Study 34097713 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone alone
Number of subjects: 100
Study 33731164 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin (powder, 1 g) applied before water-tight closure of the joint capsule
Number of subjects: 2024
Study 33731164 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (no vancomycin)
Number of subjects: 2024
Study 33067287 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand-alone VR (6-week, internet-based intervention with weekly online sessions and daily exercises)
Number of subjects: 202
Study 33067287 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended VR (same intervention supplemented with physiotherapy support)
Number of subjects: 202
Study 33067287 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 202
Study 35830423 — intervention group
Group type: EXPERIMENTAL
Intervention: ZeroPhobia: Arachnophobia, a 6‐week Augmented Reality Exposure Therapy smartphone self‐help application
Number of subjects: 112
Study 35830423 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 112
Study 34167313 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy
Number of subjects: 0
Study 35012962 — intervention group
Group type: EXPERIMENTAL
Intervention: Plitidepsin 1.5 mg once daily for 3 days
Number of subjects: 46
Study 35012962 — intervention group
Group type: EXPERIMENTAL
Intervention: Plitidepsin 2.0 mg once daily for 3 days
Number of subjects: 46
Study 35012962 — intervention group
Group type: EXPERIMENTAL
Intervention: Plitidepsin 2.5 mg once daily for 3 days
Number of subjects: 46
Study 35012962 — intervention group
Group type: EXPERIMENTAL
Intervention: Plitidepsin (all doses)
Number of subjects: 46
Study 32295593 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) high-dose ICS (160 μg mometasone furoate)
Number of subjects: 116
Study 32295593 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) medium-dose ICS (80 μg mometasone furoate)
Number of subjects: 116
Study 32295593 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol/fluticasone propionate (SFC) high-dose ICS (50/500 μg)
Number of subjects: 116
Study 32295593 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) high-dose ICS
Number of subjects: 116
Study 32295593 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) medium-dose ICS
Number of subjects: 116
Study 34818300 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization using a 4-step protocol
Number of subjects: 0
Study 32870122 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended release naltrexone (XR‐NTX)
Number of subjects: 308
Study 32870122 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 308
Study 33147123 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculated with mycelial plugs from 5-day-old PDA colonies of Lasiodiplodia theobromae
Number of subjects: 15
Study 33147123 — intervention group
Group type: COMPARATOR
Intervention: Sterile PDA plugs (negative control)
Number of subjects: 15
Study 33253691 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation of a foot-related region in the anterior precuneus
Number of subjects: 0
Study 33253691 — intervention group
Group type: COMPARATOR
Intervention: Stimulation of a control region in the middle intraparietal sulcus (mIPS)
Number of subjects: 0
Study 33253691 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 0
Study 32239659 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160
Study 32239659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study 35952370 — intervention group
Group type: EXPERIMENTAL
Intervention: Grading of shoulder bursitis by fellowship trained musculoskeletal radiologists
Number of subjects: 70
Study 35952370 — intervention group
Group type: EXPERIMENTAL
Intervention: Years of experience of radiologists
Number of subjects: 70
Study 33515069 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD) adherence in childhood
Number of subjects: 441
Study 33515069 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalization of celiac serology in childhood
Number of subjects: 441
Study 33515069 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up visits in childhood
Number of subjects: 441
Study 33515069 — intervention group
Group type: EXPERIMENTAL
Intervention: Serology testing in adulthood
Number of subjects: 441
Study 33515069 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalization of serology in adulthood
Number of subjects: 441
Study 33515069 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at gastroenterology clinic in adulthood
Number of subjects: 441
Study 33515069 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of negative serology after age 18
Number of subjects: 441
Study 33515069 — intervention group
Group type: EXPERIMENTAL
Intervention: CD-related complications
Number of subjects: 441
Study 33206761 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suprascapular nerve block (C‐SSNB)
Number of subjects: 118
Study 33206761 — intervention group
Group type: COMPARATOR
Intervention: Single-shot interscalene brachial plexus block (S‐ISNB)
Number of subjects: 118
Study 35556169 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-textbook outcome (non-TO) group
Number of subjects: 613
Study 35556169 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms based on non-TO
Number of subjects: 613
Study 35556169 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram score
Number of subjects: 613
Study 34469767 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadpill treatment (irbesartan 37.5 mg, amlodipine 1.25 mg, indapamide 0.625 mg, bisoprolol 2.5 mg)
Number of subjects: 591
Study 34469767 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadpill treatment
Number of subjects: 591
Study 34469767 — intervention group
Group type: COMPARATOR
Intervention: Standard dose monotherapy (irbesartan 150 mg)
Number of subjects: 591
Study 34469767 — intervention group
Group type: COMPARATOR
Intervention: Standard dose monotherapy
Number of subjects: 591
Study 35671123 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone treatment
Number of subjects: 92
Study 35671123 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 92
Study 32362238 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity intervention (Motivational interviewing, dietary advice on prescription, grocery store lecture, website, weekly e-mails)
Number of subjects: 289
Study 32362238 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity intervention (cookbooks and dietary lectures)
Number of subjects: 289
Study 32362238 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 289
Study 32362238 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity group
Number of subjects: 289
Study 35532889 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg testosterone enanthate weekly (n=24)
Number of subjects: 50
Study 35532889 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=26)
Number of subjects: 50
Study 33545945 — intervention group
Group type: EXPERIMENTAL
Intervention: Pestle needle therapy applied to acupoints (bilateral Shao ze, bilateral Ru gen, Dan zhong, 8 array acupoints of Shen dao) once a day for 5 days
Number of subjects: 128
Study 33545945 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care of milk deficiency
Number of subjects: 128
Study 33545945 — intervention group
Group type: EXPERIMENTAL
Intervention: Pestle needle therapy
Number of subjects: 128
Study 34563412 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal circumcision + antibiotic prophylaxis (CATB)
Number of subjects: 91
Study 34563412 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic prophylaxis alone (ATB)
Number of subjects: 91
Study 32278783 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 5898
Study 32278783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5898
Study 33804374 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking backward on a treadmill for 30 min, three times a week for four weeks
Number of subjects: 16
Study 33804374 — intervention group
Group type: COMPARATOR
Intervention: Traditional physical therapy for 30 min, three times a week for four weeks
Number of subjects: 16
Study 36288583 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided Erector Spinae Block (ESB) with 25 mg bupivacaine 0.5% plus 8 mg dexamethasone (10 mL volume)
Number of subjects: 90
Study 36288583 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided Thoracic Paravertebral Block (PVB) with 25 mg bupivacaine 0.5% plus 8 mg dexamethasone (10 mL volume)
Number of subjects: 90
Study 36288583 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study 33465277 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-06372865 (25 mg twice daily for 14 days after titration for 7 days)
Number of subjects: 19
Study 33465277 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-06372865 (42.5 mg twice daily for 14 days after titration for 7 days)
Number of subjects: 19
Study 33465277 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-06372865
Number of subjects: 19
Study 33465277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 32533797 — intervention group
Group type: EXPERIMENTAL
Intervention: Web‐Push survey protocol
Number of subjects: 14709
Study 32533797 — intervention group
Group type: COMPARATOR
Intervention: Standard mailed paper and pencil protocol
Number of subjects: 14709
Study 35436355 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose melatonin (5.0 mg)
Number of subjects: 24
Study 35436355 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose melatonin (0.3 mg)
Number of subjects: 24
Study 35436355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33566065 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin-assisted therapy
Number of subjects: 0
Study 33566065 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32739044 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated ventilation (adaptive support ventilation)
Number of subjects: 220
Study 32739044 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 220
Study 35353163 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal estradiol (10-μg)
Number of subjects: 144
Study 35353163 — intervention group
Group type: COMPARATOR
Intervention: Moisturizer
Number of subjects: 144
Study 35353163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 34483029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 24 mg
Number of subjects: 157
Study 34483029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 12 mg
Number of subjects: 157
Study 34483029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 34483029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 24 mg and 12 mg
Number of subjects: 157
Study 36328190 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea angustifolia 6cH and Avena sativa 6cH
Number of subjects: 18
Study 32508080 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual (AV) task with mouth movements
Number of subjects: 0
Study 32508080 — intervention group
Group type: COMPARATOR
Intervention: Auditory-only trials with static picture of a speaker
Number of subjects: 0
Study 35599913 — intervention group
Group type: EXPERIMENTAL
Intervention: Greek yogurt (GY), 3 servings/day, 115 kcal, 17 g protein, 11.5 g carbohydrates
Number of subjects: 13
Study 35599913 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate control (CHO), 3 servings/day, 115 kcal, 0.04 g protein, 28.6 g carbohydrates
Number of subjects: 13
Study 34599919 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD+ (n=28)
Number of subjects: 89
Study 34454821 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative Atrial Fibrillation (POAF) within seven days after cardiac surgery
Number of subjects: 910
Study 34454821 — intervention group
Group type: COMPARATOR
Intervention: No POAF
Number of subjects: 910
Study 33864466 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Lifestyles (HL) intervention, a 6 month multilevel intervention including educational workshop, self-monitoring, feedback, raffle incentive, social support, and center director coaching.
Number of subjects: 250
Study 33864466 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of HL intervention components.
Number of subjects: 250
Study 33864466 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring component of HL intervention.
Number of subjects: 250
Study 33864466 — intervention group
Group type: EXPERIMENTAL
Intervention: Raffle and social support components of HL intervention.
Number of subjects: 250
Study 34870791 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastropexy
Number of subjects: 200
Study 34870791 — intervention group
Group type: COMPARATOR
Intervention: LSG without gastropexy
Number of subjects: 200
Study 32330277 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dosage CQ (600 mg CQ twice daily for 10 days)
Number of subjects: 81
Study 32330277 — intervention group
Group type: COMPARATOR
Intervention: Low-dosage CQ (450 mg twice daily on day 1 and once daily for 4 days)
Number of subjects: 81
Study 32330277 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dosage CQ
Number of subjects: 81
Study 32330277 — intervention group
Group type: COMPARATOR
Intervention: Low-dosage CQ
Number of subjects: 81
Study 33011207 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT + HDR-BTb
Number of subjects: 216
Study 33011207 — intervention group
Group type: COMPARATOR
Intervention: EBRT alone
Number of subjects: 216
Study 32967528 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven daily sessions of mindfulness training
Number of subjects: 332
Study 32967528 — intervention group
Group type: COMPARATOR
Intervention: One-off mindfulness training session
Number of subjects: 332
Study 36329182 — intervention group
Group type: EXPERIMENTAL
Intervention: ta‐VNS
Number of subjects: 40
Study 36329182 — intervention group
Group type: COMPARATOR
Intervention: sham ta‐VNS
Number of subjects: 40
Study 32563253 — intervention group
Group type: EXPERIMENTAL
Intervention: Amaranth seed oil (ASO) 20 mL/d
Number of subjects: 81
Study 32563253 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapeseed oil (RSO) 20 mL/d
Number of subjects: 81
Study 32563253 — intervention group
Group type: COMPARATOR
Intervention: Control group (C; untreated)
Number of subjects: 81
Study 35337314 — intervention group
Group type: EXPERIMENTAL
Intervention: Back exercises (strengthening and stretching exercises)
Number of subjects: 44
Study 35337314 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 44
Study 33572918 — intervention group
Group type: EXPERIMENTAL
Intervention: Semolina spaghetti
Number of subjects: 30
Study 33572918 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholegrain spaghetti
Number of subjects: 30
Study 33572918 — intervention group
Group type: COMPARATOR
Intervention: Wheat-based mee pok noodles
Number of subjects: 30
Study 33572918 — intervention group
Group type: COMPARATOR
Intervention: Rice
Number of subjects: 30
Study 36343646 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of hypertonic saline
Number of subjects: 594
Study 36343646 — intervention group
Group type: COMPARATOR
Intervention: Continuation of hypertonic saline
Number of subjects: 594
Study 36343646 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of dornase alfa
Number of subjects: 594
Study 36343646 — intervention group
Group type: COMPARATOR
Intervention: Continuation of dornase alfa
Number of subjects: 594
Study 34294784 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) < 130 mmHg
Number of subjects: 0
Study 34294784 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) 120-129 mmHg
Number of subjects: 0
Study 34294784 — intervention group
Group type: COMPARATOR
Intervention: Systolic blood pressure (SBP) ≥ 130 mmHg
Number of subjects: 0
Study 34294784 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure (DBP) ≥ 90 mmHg
Number of subjects: 0
Study 34294784 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure < 130/80 mmHg
Number of subjects: 0
Study 32081767 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (breastfeeding support and nutrition education during 10 home visits, birth to 24 months)
Number of subjects: 106
Study 32081767 — intervention group
Group type: EXPERIMENTAL
Intervention: Days with caffeine consumption
Number of subjects: 106
Study 32081767 — intervention group
Group type: COMPARATOR
Intervention: Days without caffeine consumption
Number of subjects: 106
Study 32081767 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine consumption
Number of subjects: 106
Study 32081767 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall dietary intake
Number of subjects: 106
Study 34008811 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking Training (WT)
Number of subjects: 35
Study 34008811 — intervention group
Group type: COMPARATOR
Intervention: Control (30 min of stretching)
Number of subjects: 35
Study 32729657 — intervention group
Group type: EXPERIMENTAL
Intervention: Derivation cohort (n = 1,931)
Number of subjects: 2588
Study 32729657 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation cohort (n = 644)
Number of subjects: 2588
Study 34100365 — intervention group
Group type: EXPERIMENTAL
Intervention: Gap Balancing (GB) technique
Number of subjects: 99
Study 34100365 — intervention group
Group type: COMPARATOR
Intervention: Measured Resection (MR) technique
Number of subjects: 99
Study 33143647 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic microfracture with atelocollagen augmentation (group 1, n = 31)
Number of subjects: 60
Study 33143647 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic microfracture alone (group 2, n = 29)
Number of subjects: 60
Study 33143647 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic microfracture with atelocollagen augmentation (group 1)
Number of subjects: 60
Study 33143647 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic microfracture alone (group 2)
Number of subjects: 60
Study 616063504 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 29
Study 616063504 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 29